GleamWall
中文EN

BIOF BLUE BIOFUELS, INC.

Industrial Organic Chemicals · OTC · SEC CIK 1549145 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY—
TTM net income YoY-21.1%
TTM EPS YoY-18.2%
Revenue 3-yr CAGR—
Net income 3-yr CAGR—

Margins

Gross margin—
Operating margin—
Net margin—
FCF margin—
EBITDA margin—

Returns

ROE—
ROA-288.0%
ROIC (approx.)—
Asset turnover—

Leverage & solvency

Liabilities / assets436.2%
Debt / equity—
Current ratio0.01x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.35x
Accruals ratio-187.8%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31
Income statement
Revenue——
R&D expense$2.31M$2.33M
SG&A expense$1.41M$1.73M
Operating income-$3.72M-$4.06M
Net income-$2.87M-$1.42M
EBITDA-$3.57M-$3.94M
EPS (basic)-0.01-0.01
EPS (diluted)-0.01-0.01
Weighted avg. shares (diluted)312.19M303.85M
Balance sheet
Cash & equivalents$65,200$48,797
Current assets$76,751$81,286
PP&E, net$555,109$539,648
Intangibles$61,098—
Total assets$1.41M$1.39M
Current liabilities$2.98M$2.21M
Total liabilities$5.11M$4.24M
Shareholders' equity-$3.71M-$2.85M
Shares outstanding317.87M307.96M
Cash flow statement
Operating cash flow-$845,002-$1.00M
Capital expenditure$68,898$71,138
Free cash flow-$913,900-$1.07M
Investing cash flow-$137,345-$115,791
Financing cash flow$998,750$1.13M
Depreciation & amortization$145,852$118,798
Stock-based compensation$956,610$1.65M

Free plan shows the latest 2 periods; Pro shows all 12 🔒

· This company does not report gross profit in XBRL.

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-21 06:27.